Dx Focus: Clinical and Regulatory PCR and Nucleic Acid Testing News
March 23, 2010
Dx Focus: Clinical and Regulatory PCR and Nucleic Acid Testing News
Meridian Bioscience's Illumigene C. difficile test; Nanosphere's Verigene SP respiratory virus panel; Veredus Laboratories' VereFlu test and VereID Biosystem; and IMDx's 2009 influenza H1N1 assay
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Nanosphere Releases Data on Gram-Positive Blood Culture Test Ahead of Anticipated FDA Approval
October 4, 2011 / BioArray News - Quidel Obtains CE Mark for AmpliVue C. Difficile, Company's First Handheld MDx Test
March 29, 2012 / PCR Insider - Despite 12 Percent Drop in Q1 Sales, Meridian Bioscience Maintains Positive FY '11 Outlook
January 20, 2011 / PCR Insider - Dx Focus: BD Max Cdiff; Hologic Aptima HPV; Inostics BEAMing Tech; Veredus Labs VereFlu Test
April 11, 2013 / PCR Insider - Dx Focus: Meridian's Illumigene Group A, B Strep Tests; Cynvenio Biosystems' LiquidBiopsy Service
March 21, 2013 / PCR Insider